The pharmacodynamic effect on cardiac repolarization of combination single dose ZD6474 and ondansetron in healthy subjects

3197 Background: ZD6474, a selective inhibitor of VEGFR-2 and EGFR tyrosine kinase activity, is being evaluated in combination with certain chemotherapy agents as part of an ongoing Phase II progra...